Neulasta Related Clinical Trials
Pegfilgrastim (Neulasta) for Stem Cell Mobilization in Patients With Multiple Myeloma [Completed]
Pegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast Cancer [Active, not recruiting]
Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During Chemotherapy [Completed]
Neulasta in Type 1 Diabetes [Recruiting]
Evaluation of Loratadine for Prevention of Pegfilgrastim-Induced Pain [Recruiting]
Pharmacokinetic/Pharmacodynamic (PK/PD) Study Evaluating Pegfilgrastim Hospira Compared to Neulasta (Amgen) in Healthy Volunteers [Recruiting]
Chemotherapy Administered Every 2 Weeks With or Without Pegfilgrastim (Neulasta) in Subjects With Advanced Colon Cancer [Active, not recruiting]
Pegfilgrastim PBPC Mobilization Study [Completed]
Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Neulasta� [Recruiting]
Pharmacokinetics and Pharmacodynamics Study of Pegfilgrastim in Chemotherapy Patients [Recruiting]
Pegfilgrastim and Rituximab in Treating Patients With Untreated, Relapsed, or Refractory Follicular Lymphoma, Small Lymphocytic Lymphoma, or Marginal Zone Lymphoma [Recruiting]
Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim [Recruiting]
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer [Recruiting]
Trial Comparing Pegfilgrastim With Filgrastim as an Adjunct to Chemotherapy for Acute Myeloid Leukaemia (AML) [Completed]
Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer [Recruiting]
Horse ATG in Patients With AA or Low/Int-1 Risk MDS [Recruiting]
PAVES: Pegfilgrastim Anti-VEGF Evaluation Study [Recruiting]
Gemcitabine, Paclitaxel, Doxorubicin, and Pegfilgrastim in Treating Patients With Metastatic or Unresectable Bladder Cancer or Urinary Tract Cancer and Kidney Dysfunction [Recruiting]
Dacarbazine and Carmustine in Metastatic Melanoma [Recruiting]
A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer [Completed]
Dose Dense TC + Pegfilgrastim Support for Breast Cancer [Recruiting]
Phase 2 Study of HM10460A or Pegfilgrastim Use for the Management of Neutropenia in Breast Cancer Patients [Not yet recruiting]
Inotuzumab Ozogamycin in Elderly Acute Lymphoblastic Leukemia (ALL) [Recruiting]
Video Impact on Neulasta Education [Recruiting]
A Prospective Feasibility and Cost Analysis of Peripheral Blood Stem Cell Mobilization Using Pegfilgrastim in Patients With Hematologic Malignancies [Recruiting]
Dose-Dense MVAC With Pegfilgrastim Support in Subjects With Muscle-Invasive Urothelial Carcinoma [Recruiting]
Aranesp and Neulasta in Patients With Sarcoma Receiving Adriamycin and Ifosfamide [Suspended]
NOLAN: Naproxen or Loratadine and Neulasta [Recruiting]
Dose-Finding Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy [Recruiting]
Pharmacokinetics and Pharmacodynamics of a Novel Pegylated Recombinant Human Granulocyte-Colony Stimulating Factor [Recruiting]
Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine Sulfate, Prednisone, Rituximab, Pegfilgrastim, and Sargramostim as Front-Line Therapy in Treating Patients With Aggressive Non-Hodgkin Lymphoma [Recruiting]
Rituximab and Pegfilgrastim in Treating Patients With Non-Hodgkin's Lymphoma [Recruiting]
Pegfilgrastim Administered on the Same Day as Chemotherapy in Non-Hodgkin's Lymphoma [Active, not recruiting]
Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy [Completed]
A Study of Cyclophosphamide/Methotrexate/5-Fluorouracil (CMF) With Pegfilgrastim in Subjects With Breast Cancer [Completed]
Pegfilgrastim for Stem Cell Mobilization in Children (Meg-5) [Not yet recruiting]
Pegfilgrastim Given Same Day As or Day After Carboplatin and Docetaxel in Advanced Metastatic Non-Small Cell Lung Cancer (NSCLC) [Active, not recruiting]
FIRST - Study of Pegfilgrastim Administered in the First and Subsequent Cycles of Myelosuppressive Chemotherapy [Active, not recruiting]
Study on All-Trans Retinoic Acid, Induction and Consolidation Therapy, and Pegfilgrastim After Consolidation Therapy in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia [Recruiting]
Same Day Dosing of Pegfilgrastim in Breast Cancer Patients Undergoing Chemotherapy (TAC) [Completed]
Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer [Recruiting]
Treatment for Elderly Patients With High Risk Breast Cancer [Completed]
Pegfilgrastim Versus Filgrastim After High-Dose Chemotherapy [Completed]
Combination Chemotherapy With or Without Fluorouracil and/or Pegfilgrastim in Treating Women With Node-Positive Breast Cancer [Active, not recruiting]
Stem Cell Mobilization With Pegfilgrastim in Lymphoma and Myeloma [Recruiting]
Combination Chemotherapy With or Without Pegfilgrastim as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer [No longer recruiting]
Peg-Granulocyte-Colony Stimulating Factor (GCSF) for Coronary Collateral Growth in Coronary Artery Disease Patients [Recruiting]
Filgrastim or Pegfilgrastim in Preventing Neutropenia in Women Receiving Chemotherapy Following Surgery for Breast Cancer [Active, not recruiting]
Study of R-ACVBP Regimen Supported by Pegfilgrastim in High-Risk Diffuse Large B-Cell Lymphoma [Completed]
Ph I 5-Day Temo + O6-BG in Treatment of Pts w Recurrent / Progressive GBM [Active, not recruiting]
Phase 2 Study of the Activity and Safety of Fludarabine, Cyclophosphamide, and Mitoxantrone Plus Rituximab (FCM-R) With Pegfilgrastim (Neulasta) as Frontline Therapy for Patients < 70 Years With Chronic Lymphocytic Leukemia [Suspended]
ACCELERATE: Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Pegfilgrastim and Darbepoetin Alfa Support for the Treatment of Women With Breast Cancer [Recruiting]
Pegfilgrastim Vs. Filgrastim - Comparison of Mobilized Blood Stem Cells in Patients With Non Hodgkin-Lymphoma [Recruiting]
Naproxen in Preventing Bone Pain Caused by Pegfilgrastim in Patients With Non-Hematologic Cancer Undergoing Chemotherapy [Recruiting]
Pegfilgrastim Compared With Filgrastim To Increase Peripheral Stem Cells Before Autologous Stem Cell Transplantation in Treating Patients With Lymphoma [Active, not recruiting]
A Study of Carboplatin/Paclitaxel With Pegfilgrastim Supported by Haematopoietic Progenitor Cell Re-Infusion in Whole Blood [Completed]
Neugranin in Breast Cancer Patients Receiving Doxorubicin/Docetaxel (NEUGR-003) [Recruiting]
Treatment for Subjects With Non-Hodgkin's Lymphoma [Completed]
High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Newly Diagnosed Stage I, Stage II, or Stage III Multiple Myeloma [Recruiting]
Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy [Completed]
Hyper-CVAD and Ponatinib in Ph-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia (ALL) [Recruiting]
Dose Finding Study of KRN125 (Pegfilgrastim) for Treatment of Neutropenic Patients [Completed]
Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer [Recruiting]
Combination Chemotherapy and Pegfilgrastim in Treating Men With Metastatic Germ Cell Tumors [Recruiting]
Reversing Type 1 Diabetes After it is Established [Recruiting]
Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Recruiting]
Evaluation of Pegfilgrastim for Stem Cell Mobilization in Children [Terminated]
A Study of Peripheral Blood Progenitor Cell (PBPC) Mobilisation by Chemotherapy With Pegfilgrastim or Filgrastim in Subjects With Non-Hodgkin's Lymphoma [Completed]
Evaluating Pegfilgrastim and a Multi-Day Topotecan Regimen in Subjects With Relapsed or Refractory Ovarian Cancer [Completed]
Bortezomib Plus ICE (BICE) Versus Standard ICE for Patients With Relapsed/Refractory Classical Hodgkin Lymphoma [Recruiting]
Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen [Recruiting]
Rituximab&Methotrexate Chemotherapy w/BBBD & Sodium Thiosulfate Chemoprotection for Patients With Newly Diagnosed PCNSL [Recruiting]
Combined Modality Therapy With Growth Factor Support in Locally Advanced Non-Small Cell Lung Cancer (NSCLC) [Recruiting]
Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors [Recruiting]
Panobinostat Plus Ifosfamide, Carboplatin, and Etoposide (ICE) Compared With ICE For Relapsed Hodgkin Lymphoma [Recruiting]
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer [Active, not recruiting]
Docetaxel, Gemcitabine, and Filgrastim (G-CSF) or Pegfilgrastim in Treating Patients With Advanced, Persistent, or Recurrent Uterine Leiomyosarcoma [Active, not recruiting]
Combination Chemotherapy With BBBD Followed By Sodium Thiosulfate in Treating Patients With Anaplastic Oligodendroglioma or Oligoastrocytoma [Recruiting]
Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma [Recruiting]
Docetaxel, Trabectedin, and G-CSF or Pegfilgrastim in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer [Recruiting]
Rituximab, Cyclophosphamide, and Pegfilgrastim in Treating Patients With Leukemia or Non-Hodgkin's Lymphoma [Recruiting]
Combination Chemotherapy and Filgrastim or Pegfilgrastim in Treating Patients With Recurrent or Persistent Cancer of the Uterus [Active, not recruiting]
Dose Dense Adjuvant CMF (Cyclophosphamide, Methotrexate, Fluorouracil) at 14 and 10-11 Day Intervals for Women With Early Stage Breast Cancer [Recruiting]
G-CSF and Pegfilgrastim in Treating Neutropenia in Patients Undergoing Radiation Therapy and Chemotherapy for Limited Stage Small Cell Lung Cancer [Recruiting]
Trial Exploring Feasibility of Densification and Optimal Sequencing of Postoperative Adjuvant Fluorouracil, Epirubicin Plus Cyclophosphamide (FEC) and Docetaxel Chemotherapy in Patients With High Risk Primary Operable Breast Cancer
Induction Chemotherapy Using Paclitaxel, Carboplatin, CPT-11 With Pegfilgrastim Followed by Radiotherapy and Paclitaxel/Carboplatin/ZD1839 in Locally Advanced Unresectable Stage IIIA/B Non-Small Cell Carcinoma of the Lung [Completed]
Evaluate PKs and Efficacy Assessment of Palifermin in Patients With Sarcoma [Active, not recruiting]
Phase II Trial of Dose-Dense Paclitaxel and Cisplatin as Neo-Adjuvant Chemotherapy for Operable Stage II and IIA NSCLC [Terminated]
Melphalan, Carboplatin, and Sodium Thiosulfate for Patients With Central Nervous System (CNS) Embryonal or Germ Cell Tumors [Recruiting]
Study of Dose-Dense Adriamycin Plus Cytoxan (AC) Followed by Either Abraxane or Taxol With Bevacizumab as Adjuvant Therapy for Patients With Breast Cancer [Active, not recruiting]
Efficacy Study of Outpatient Therapy for Lymphoma [Completed]
Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Combination Chemotherapy and Rituximab With Pegfilgrastim Followed by Rituximab, in Large B-Cell Non-Hodgkin's Lymphoma [Active, not recruiting]
Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma [Recruiting]
Various G-CSF Regimens to Prevent Infection During Chemotherapy [Not yet recruiting]
Study of Sequential Topoisomerase, Irinotecan/Oxaliplatin - Etoposide /Carboplatin in Extensive SCLC [Recruiting]
Six vs 12 Months of Transtuzumab With Docetaxel Following FEC as Adjuvant Treatment in N+ Breast Cancer [Recruiting]
A Pilot Study of Standard-Dose Rituximab, Ifosfamide, Carboplatin and Etoposide (RICE) Plus Bortezomib (Velcade) in a Dose-Escalating Fashion for Patients With Relapsed or Primary Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma Who Are Candidates for Autologous Stem Cell Transplant [Recruiting]
Dose Augmented Rituximab and Ice for Patients With Primary Refractory and Poor Risk Relapsed Aggressive B-Cell Non-Hodgkin's Lymphoma [Recruiting]
Dose Density FU 75 and FU 90 as Adjuvant Therapy for Early Breast Cancer [Completed]
Rituximab in Combination With Outpatient Therapy for CD20+ Lymphoma [Recruiting]
|
